Astrotech Announces Annual Shareholders Meeting and Investor Tour of 1st Detect on June 30, 2015
By Business Wire News
By Business Wire News
Astrotech Corporation (Nasdaq:ASTC), a leader in the commercialization of government sponsored advanced space technologies, today announced that the company will host its annual meeting of shareholders at 9AM CST on June 30, 2015 at the 1st Detect Headquarters located at 555 Forge River Road, Suite 100, Webster, TX 77598. In conjunction with this meeting, the company will be providing investors with a laboratory and factory tour, and will include full demonstrations of their products. Astrotech and 1st Detect management will be available to answer questions.
The materials for this shareholder meeting including the proxy statement, Form 10-K and Form 10-Q are available at http://www.astrotech.com/investors/proxy-statements.
For more information, please select the following link to register:
Astrotech Corporation is an Austin, TX based technology company that has evolved from over 30 years in the human spaceflight, Space Shuttle, and Department of Defense satellite programs. The company has become a leader in the commercialization of government sponsored advanced space technologies.
1st Detect Corporation has developed a mass spectrometer that was designed for use on the International Space Station, but also revolutionizes the chemical detection and analysis market by delivering laboratory performance mass spectrometry in a small, affordable, and portable package. 1st Detect’s technology is useful in the semiconductor, food & beverage processing, laboratory, process control, explosive detection, and chemical warfare markets.
Astrogenetix Corporation is the result of over $4 Billion spent by NASA over a 25 year period on experiments conducted in sustained microgravity, where results were only achieved while orbiting in space. Astrotech designed and flew 1,113 of these experiments and after an extensive review, discovered that microgravity greatly enhanced the discovery of valuable vaccine and therapeutics. The company has completed 12 successful biomarker discovery missions to the International Space Station and has identified a salmonella vaccine candidate, while 10 additional discoveries are in the pipeline. NASA has awarded Astrogenetix 26 free flights to the $130 Billion ISS National Laboratory, along with full crew support.
Astral Images, Inc. is positioned to be the world leader in the technology required to convert and repair feature films and film based television series to the new digital HDR Ultra-High Definition 4K standards. Astral’s IP includes technology from IBM and Kodak, which represent the state-of-the-art defect correction technologies.
Joshua Elbaum, VP, Marketing, 512-485-9530